VP Regulatory Affairs Rizwana F Sproule sold $531K of Kite Pharma, Inc.

Sold$530,831

$55.49Price

9,567Shares

−52%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Fri, Jan 15. Filed Tue, Jan 19, 3:23 PM ET, during the session. Not investment advice.